These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16253559

  • 1. The search for a tuberculosis vaccine: an elusive quest?
    Nagelkerke NJ, de Vlas SJ, Mahendradhata Y, Ottenhoff TH, Borgdorff M.
    Tuberculosis (Edinb); 2006 Jan; 86(1):41-6. PubMed ID: 16253559
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3. The second Geneva Consensus: Recommendations for novel live TB vaccines.
    Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH.
    Vaccine; 2010 Mar 08; 28(11):2259-70. PubMed ID: 20074686
    [Abstract] [Full Text] [Related]

  • 4. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL, Pan Q, Ma Y, Wang K, Sun P, Liu S, Zhang XL.
    Vaccine; 2009 Nov 12; 27(48):6712-22. PubMed ID: 19733584
    [Abstract] [Full Text] [Related]

  • 5. Development of vaccines against tuberculosis.
    Tyagi AK, Nangpal P, Satchidanandam V.
    Tuberculosis (Edinb); 2011 Sep 12; 91(5):469-78. PubMed ID: 21334259
    [Abstract] [Full Text] [Related]

  • 6. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J, Doherty TM.
    APMIS; 2009 May 12; 117(5-6):440-57. PubMed ID: 19400867
    [Abstract] [Full Text] [Related]

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 12; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 8. Advances in tuberculosis vaccine strategies.
    Skeiky YA, Sadoff JC.
    Nat Rev Microbiol; 2006 Jun 12; 4(6):469-76. PubMed ID: 16710326
    [Abstract] [Full Text] [Related]

  • 9. A rational vaccine pipeline for tuberculosis.
    Brennan MJ, Stone MR, Evans T.
    Int J Tuberc Lung Dis; 2012 Dec 12; 16(12):1566-73. PubMed ID: 23131253
    [Abstract] [Full Text] [Related]

  • 10. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z, Charters TJ.
    Expert Rev Vaccines; 2007 Aug 12; 6(4):539-46. PubMed ID: 17669008
    [Abstract] [Full Text] [Related]

  • 11. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
    Hovav AH, Bercovier H.
    Tuberculosis (Edinb); 2006 Aug 12; 86(3-4):225-35. PubMed ID: 16515885
    [Abstract] [Full Text] [Related]

  • 12. Challenge of developing new tuberculosis vaccines to generate life-long protective immunity.
    Triccas JA, Nambiar JK.
    Expert Rev Vaccines; 2009 Jul 12; 8(7):823-5. PubMed ID: 19538108
    [No Abstract] [Full Text] [Related]

  • 13. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG.
    Tuberculosis (Edinb); 2006 Jul 12; 86(3-4):169-78. PubMed ID: 16677860
    [Abstract] [Full Text] [Related]

  • 14. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST, Kaufmann SH.
    Int J Med Microbiol; 2008 Jan 12; 298(1-2):143-50. PubMed ID: 17702652
    [Abstract] [Full Text] [Related]

  • 15. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R, Aguilar LD, Infante E, Cataldi A, Bigi F, Martin C, Gicquel B.
    Tuberculosis (Edinb); 2006 Jan 12; 86(3-4):203-10. PubMed ID: 16542875
    [Abstract] [Full Text] [Related]

  • 16. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB, Plikaytis BB, Shinnick TM.
    Vaccine; 2007 Feb 19; 25(9):1553-66. PubMed ID: 17166640
    [Abstract] [Full Text] [Related]

  • 17. Tuberculosis vaccine research: the impact of immunology.
    Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.
    Curr Opin Immunol; 2009 Jun 19; 21(3):331-8. PubMed ID: 19505813
    [Abstract] [Full Text] [Related]

  • 18. Vaccine approaches to prevent tuberculosis.
    Wiker HG, Mustafa T, Målen H, Riise AM.
    Scand J Immunol; 2006 Sep 19; 64(3):243-50. PubMed ID: 16918693
    [Abstract] [Full Text] [Related]

  • 19. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.
    Glatman-Freedman A.
    Tuberculosis (Edinb); 2006 Sep 19; 86(3-4):191-7. PubMed ID: 16584923
    [Abstract] [Full Text] [Related]

  • 20. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J, Vipond R, Allen-Vercoe E, Clark SO, Hatch GJ, Gooch KE, Bacon J, Hampshire T, Shuttleworth H, Minton NP, Blake K, Williams A, Marsh PD.
    Vaccine; 2006 Sep 11; 24(37-39):6340-50. PubMed ID: 16781800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.